MSH2 and colorectal cancer: As silencing of MLH1 by promoter methylation is known to cause loss of MLH1 protein expression in colorectal cancer [5, 19, 30], we designed a pyrosequencing assay to test for MSH2 methylation as an alternative mechanism.